ATP1A3 and drug-induced dyskinesia: As mutations in the Atp1a3 gene are known to be related to dyskinesia, epilepsies and Parkinson’s disease [43] this could be a relevant finding in the context of other reports describing a connection between the loss of Adcy5 and movement disorders like dyskinesia or autism-like behavior [44,45,46].